Jessica Ailani, MD, MedStar Georgetown University Hospital, Georgetown, Washington, DC, discusses the drawbacks of telemedicine. While there are many advantages to telemedicine, it will not be able to replace in-person visits. The building of the patient-physician relationship is hindered over virtual meetings as well as picking up subtle cues. Telemedicine can be used to improve healthcare but it should be used within its limitations. This interview took place during the Virtual World Congress on Controversies in Neurology (CONy) 2020.
Dr. Ailani has received honoraria for consulting from the following companies; Amgen, Abbvie, Biohaven, Eli Lilly and Company, Lundbeck, Teva, Impel, Satsuma, Theranica, Axsome, Vorso. She has received stock options from CtrlM for consulting. She has received honoraria for speaking engagements from the following companies; Abbvie, Amgen, Biohaven, Eli Lilly, Lundbeck, and Teva. Dr. Ailani’s institution has received funding for clinical trials for her work as principal investigator from the following companies; Allergan/Abbvie, Biohaven, Eli Lilly and Company, Satsuma, Zosano. She has provided advising and editorial services and received honoraria from the following journals/magazines/and companies; Current pain and headache reports, SELF, Neurology Live, and Medscape.